(Reuters) -Drugmaker AbbVie is in talks to acquire privately-held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about $1 billion, Bloomberg News reported on Wednesday, citing people familiar with the matter.
(Reporting by Christy Santhosh in Bengaluru; Editing by Mohammed Safi Shamsi)
